Biotricity, Inc. (BTCY) Research

Headquartered in Redwood City, California, Biotricity, Inc. is a medical technology enterprise delivering biometric data monitoring solutions, primarily within the United States. The company's efforts are dedicated to supplying remote monitoring capabilities to the medical, healthcare, and individual consumer markets, encompassing both diagnostic tools and ongoing management support for chronic and lifestyle-related conditions. Among its key offerings are the Bioflux mobile cardiac telemetry solution, an integrated ECG device, alongside specialized ECG analysis software designed to process and synthesize patient heart rhythm data, complemented by various software components.

Market snapshot

Symbol
BTCY
Price
$0.12
Day change
+0.63%
Market cap
$3.4M
P/E ratio
-0.83x
52-week range
0.1-0.7536
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 6 days
Analyst price target
$4.00

Peer companies

  • ALR Technologies Inc. (ALRTF)
  • Aurora Spine Corporation (ASAPF)
  • Cell Source, Inc. (CLCS)
  • CareView Communications, Inc. (CRVW)
  • Gemina Laboratories Ltd. (GLABF)
  • Guided Therapeutics, Inc. (GTHP)
  • Immunovia AB (publ) (IMMVF)
  • RYAH Group, Inc. (RYAHF)

Recent insider activity

  • Rosa David A — A-Award (75930 shares) on 2023-03-12
  • Al-Siddiq Waqaas — A-Award (1000000 shares) on 2023-03-12
  • Al-Siddiq Waqaas — A-Award (350000 shares) on 2023-03-12
  • Al-Siddiq Waqaas — A-Award (350000 shares) on 2023-03-12
  • Ayanoglou John — A-Award (218785 shares) on 2022-12-31

Open Biotricity, Inc. (BTCY) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.